Related Experiment Video
Updated: Aug 6, 2026

CO2-Lasertonsillotomy Under Local Anesthesia in Adults
Published on: November 6, 2019
Local treatment of minor aphthous ulceration in children
J R Jasmin1, M Muller-Giamarchi, N Jonesco-Benaiche
1Department of Pedodontics, UFR d'Odontologie, Nice, France.
Insights
Minor aphthous ulceration in children causes pain, often from infection. Applying a cyanoacrylate adhesive quickly relieves pain and speeds healing.
Area of Science:
- Pediatric Medicine
- Dermatology
Background:
- Minor aphthous ulceration is a common pediatric condition.
- Pain and secondary infection are frequent complications.
- Ulceration duration typically ranges from 18 hours to 3 days.
Purpose of the Study:
- To evaluate the efficacy of cyanoacrylate adhesive for treating pain associated with minor aphthous ulceration in children.
- To assess the impact of cyanoacrylate adhesive on ulcer healing time.
Main Methods:
- A cohort of children with minor aphthous ulceration was treated with cyanoacrylate adhesive.
- Symptomatic relief and healing duration were monitored.
Main Results:
- Cyanoacrylate adhesive application resulted in rapid symptomatic relief within minutes.
- The treatment significantly shortened the healing time of the aphthous ulcers.
Conclusions:
- Cyanoacrylate adhesive is an effective treatment for pain relief in pediatric minor aphthous ulceration.
- This intervention accelerates the healing process, reducing patient discomfort and duration of illness.
Abstract:
Pain is commonly associated with minor aphthous ulceration in children. It results mostly from secondary infection and lasts from eighteen hours to three days. The use of a cyanoacrylate adhesive provides a symptomatic relief within minutes and shortens the healing time.
Related Concept Videos
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

